当前位置: 首页 >> 检索结果
1. [Indirect comparison of anti-angiogenic agents in the treatment of diabetic macular edema].
作者: D L Klabukova.;I S Krysanov.;V S Krysanova.;V Yu Ermakova.
来源: Vestn Oftalmol. 2024年140卷6期69-79页
Diabetic macular edema (DME) is a leading cause of visual impairment and blindness among diabetic patients, its prevalence is continuing to increase worldwide. Faricimab, a bispecific antibody, represents a new generation of treatments for DME.
|